Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,222 | -27,267 | -16,413 | -6,671 | -60,663 |
| Depreciation Amortization | 2,197 | 1,634 | 1,050 | 491 | 1,564 |
| Accounts receivable | 485 | 1,355 | 1,101 | -1,927 | -1,129 |
| Accounts payable and accrued liabilities | 2,646 | -909 | -2,086 | 1,027 | 967 |
| Other Working Capital | 2,727 | 139 | -1,522 | -1,044 | -1,293 |
| Other Operating Activity | 19,983 | 8,409 | 5,733 | 2,266 | 39,865 |
| Operating Cash Flow | $-22,184 | $-16,639 | $-12,137 | $-5,858 | $-20,689 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,185 | -1,706 | -656 | -307 | -512 |
| Investing Cash Flow | $-3,185 | $-1,706 | $-656 | $-307 | $-512 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -510 | -332 | -212 | -98 | -201 |
| Common Stock Issued | 28,656 | 29,143 | 29,143 | 29,143 | 26,440 |
| Other Financing Activity | -74 | -487 | -487 | -487 | -5,810 |
| Financing Cash Flow | $28,072 | $28,324 | $28,444 | $28,558 | $20,429 |
| Exchange Rate Effect | -120 | -105 | N/A | N/A | -24 |
| Beginning Cash Position | 10,336 | 10,336 | 10,336 | 10,336 | 11,132 |
| End Cash Position | 12,919 | 20,210 | 25,987 | 32,729 | 10,336 |
| Net Cash Flow | $2,583 | $9,874 | $15,651 | $22,393 | $-796 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,184 | -16,639 | -12,137 | -5,858 | -20,689 |
| Capital Expenditure | -3,185 | -1,706 | -656 | -307 | -516 |
| Free Cash Flow | -25,369 | -18,345 | -12,793 | -6,165 | -21,205 |